01—Abstract
Summary
Summary of the 10-Q filed August 5, 2025. Cited figures are marked; the original filing is the authoritative source.
Leidos Holdings, Inc. reported higher second-quarter fiscal 2025 results, with revenues of $4,253 milliona, up from $4,132 million a year earlier (2.9%).
Operating income rose to $571 millionb from $475 million (20.2%), and operating margin improved to 13.4% from 11.5%. Net income attributable to Leidos common stockholders was $391 million, and diluted EPS was $3.01 versus $2.37. For the six months, revenues were $8,498 million (4.8% higher), operating income was $1,101 million (23.7% higher), and diluted EPS was $5.80 versus $4.42.
The company cited program wins, managed health services volume growth, and prior-year write-downs in its UK operations not recurring. Segment operating margins were 10.0% for National Security & Digital, 24.4% for Health & Civil, 7.1% for Commercial & International, and 7.6% for Defense Systems in the quarter. Backlog was $46,210 millionc at July 4, 2025, up from $41,551 million a year earlier (recast to include sole-source IDIQ task orders), and remaining performance obligations were $16 billion.
Net bookings were $3.9 billiond in the quarter and $6.0 billion for the six months. Leidos acquired Kudu Dynamics on May 23, 2025 for preliminary consideration of about $291 million net of cash acquired. Cash and cash equivalents were $930 million, and total long-term debt was $5,104 million, up from $4,670 million at fiscal year-end, after issuing $500 million of 5.40% notes due 2032 and $500 million of 5.50% notes due 2035.
Quarterly dividends were $0.40 per share. The filing also states that the One Big Beautiful Bill Act reduces expected fiscal 2025 income taxes payable by approximately $280 million and federal and state tax payments by approximately $150 million. The company disclosed an ongoing Department of Justice Antitrust Division criminal investigation linked to a 2022 grand jury subpoena and an open SEC matter, and stated it cannot estimate potential fines or liabilities.
02—Key points
Key Highlights
- Q2 fiscal 2025 revenues of $4,253 million, up 2.9% from $4,132 million; operating income of $571 million, up 20.2%, with operating margin of 13.4% versus 11.5%.
- Six-month diluted EPS of $5.80 versus $4.42 a year earlier; net income attributable to Leidos common stockholders of $754 million for the six months.
- Total backlog of $46,210 million at July 4, 2025, up from $41,551 million (recast); remaining performance obligations of $16 billion, with about 61% expected to be recognized over the next 12 months.
- Acquisition of Kudu Dynamics on May 23, 2025 for preliminary consideration of about $291 million net of cash acquired, adding $244 million of goodwill and $149 million of backlog.
- Total long-term debt rose to $5,104 million from $4,670 million after issuing $1.0 billion of senior notes in February 2025; no commercial paper or revolver borrowings outstanding.
- The One Big Beautiful Bill Act is expected to reduce fiscal 2025 income taxes payable by about $280 million and federal and state tax payments by about $150 million.
- Ongoing DOJ Antitrust Division criminal investigation tied to a 2022 grand jury subpoena and an open SEC matter; the company says it cannot estimate potential fines or liabilities.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2026, Leidos Holdings kept $0.09.
- Revenue$4.23B100.0%
- Cost of revenue−$3.47B82.0%
- Gross profit$762.0M18.0%
- Operating costs−$191.0M4.5%
- Operating income$571.0M13.5%
- Interest, other & tax−$180.0M4.3%
- Net income$391.0M9.2%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2026filed August 5, 2025Financial Statements
Q2 FY2026 against Q2 FY2025
| Line item | Q2 FY2026Q2 FY2025 | Change |
|---|---|---|
| Revenue | $4.23B$4.11B | +3.1% |
| Cost of Revenue | $3.47B$3.43B | +1.3% |
| Gross Profit | $762.00M$680.00M | +12.1% |
| SG&A Expenses | $217.00M$231.00M | −6.1% |
| Operating Income | $571.00M$475.00M | +20.2% |
| Net Income | $391.00M$322.00M | +21.4% |
| EPS (Basic) | $3.03$2.39 | +26.8% |
| EPS (Diluted) | $3.01$2.37 | +27.0% |
| Shares Outstanding (Basic) | 129.00M135.00M | −4.4% |
| Shares Outstanding (Diluted) | 130.00M136.00M | −4.4% |
05—Questions
Frequently Asked Questions
What drove the improvement in operating income this quarter?
Operating income rose to $571 million from $475 million. The filing attributes the increase mainly to program wins across segments, the Health & Civil managed health services volume growth, the non-recurrence of prior-year UK write-downs in Commercial & International, and a $25 million insurance reimbursement for legal costs recorded in Corporate.
How much cash does Leidos have and how much debt does it carry?
Cash and cash equivalents were $930 million at July 4, 2025. Total long-term debt was $5,104 million, compared with $4,670 million at January 3, 2025. The company issued $500 million of 5.40% notes due March 2032 and $500 million of 5.50% notes due March 2035 in February 2025, and used the proceeds to retire $500 million of notes due May 2025 and fund a $500 million accelerated share repurchase.
What is the impact of the One Big Beautiful Bill Act on Leidos?
The company recorded a $150 million decrease to income taxes payable and a $130 million decrease to deferred tax assets as of July 4, 2025. It estimates a fiscal 2025 decrease of approximately $280 million to income taxes payable and $245 million to net deferred taxes, and expects federal and state tax payments to fall by about $150 million in fiscal 2025. The effective tax rate rose to 24.1% for the quarter from 23.9%, mainly due to the legislation.
What legal and regulatory matters does the filing disclose?
The company says it is fully cooperating with a Department of Justice Antitrust Division criminal investigation, prompted by a federal grand jury subpoena received in August 2022 covering three U.S. government procurements. It is also conducting an internal investigation. The DOJ closed a separate inquiry in December 2024, while an SEC investigation remains open. The company states it cannot determine or reasonably estimate any resulting fines, penalties or liabilities.
How much is the company returning to shareholders?
Dividends paid were $105 million for the six months ended July 4, 2025, with a quarterly dividend of $0.40 per share. Stock repurchases in cash flow totaled $537 million for the six months, including the $500 million accelerated share repurchase agreement entered in February 2025. No open market repurchases occurred during the quarter other than shares surrendered for tax withholding.
06—Continue